<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="0742cf97-601b-4c13-a6c3-1a6a616ed292"><labelDrug name="Verapamil Hydrochloride"><Normalization/></labelDrug><generic name="verapamil hydrochloride"/><sentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.1" text="Drug Label for drug brand Verapamil Hydrochloride, containing verapamil hydrochloride." type="negative"><entity charOffset="62:85" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.1.e.0" text="verapamil hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0700468" phraseText="verapamil hydrochloride." preferredWord="Verapamil hydrochloride" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.1.e.1" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Verapamil Hydrochloride," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="26:49" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.1.e.2" text="verapamil hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0700468" phraseText="Drug Label for drug brand Verapamil Hydrochloride," preferredWord="Verapamil hydrochloride" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.1.e.1" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.1.e.0"/><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.1.e.1" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.1.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.16" lineNumber="29" text="Verapamil should be avoided in patients with severe left ventricular dysfunction (e.g., ejection fraction less than 30% or moderate to severe symptoms of cardiac failure) and in patients with any degree of ventricular dysfunction if they are receiving a beta-adrenergic blocker. " type="regular"><entity charOffset="20:27" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.16.e.1" text="avoided" type="Caution_Interaction"/><entity charOffset="206:229" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.16.e.2" text="ventricular dysfunction" type="SPAN"/><entity charOffset="254:277" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.16.e.3" text="beta-adrenergic blocker" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="a beta-adrenergic blocker." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><mmtx cui="C3536830" phraseText="a beta-adrenergic blocker." preferredWord="beta-Adrenergic Blocker [EPC]" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.16.e.4" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.16.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.16.e.1"><relations><relation type="hasContext"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.16.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.16.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.16.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.16.e.2" ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.16.e.4" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.16.e.3" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.16.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.17" text="(See DRUG INTERACTIONS. ) Patients with milder ventricular dysfunction should, if possible, be controlled with optimum doses of digitalis and/or diuretics before verapamil treatment (note interactions with digoxin under: PRECAUTIONS )." type="negative"><entity charOffset="128:137" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.17.e.0" text="digitalis" type="Biomedical_Entity"><Normalization><mmtx cui="C0304520" phraseText="controlled with optimum doses of digitalis" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="206:213" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.17.e.1" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="(note interactions with digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="145:154" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.17.e.2" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretics before verapamil treatment" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="162:171" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.17.e.3" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="diuretics before verapamil treatment" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.17.e.0" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.17.e.1"/><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.17.e.0" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.17.e.2"/><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.17.e.0" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.17.e.3"/><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.17.e.2" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.17.e.1"/><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.17.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.17.e.1"/><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.17.e.2" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.17.e.3"/></sentence><sentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.29" text="Some patients with paroxysmal and/or chronic atrial flutter or atrial fibrillation and a coexisting accessory AV pathway have developed increased antegrade conduction across the accessory pathway bypassing the AV node, producing a very rapid ventricular response or ventricular fibrillation after receiving intravenous verapamil (or digitalis). " type="negative"><entity charOffset="319:328" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.29.e.0" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="receiving intravenous verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="333:342" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.29.e.1" text="digitalis" type="Biomedical_Entity"><Normalization><mmtx cui="C0304520" phraseText="digitalis" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.29.e.0" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.29.e.1"/></sentence><sentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.40" text="In 120 patients with hypertrophic cardiomyopathy (most of them refractory or intolerant to propranolol) who received therapy with verapamil at doses up to 720 mg/day, a variety of serious adverse effects were seen. " type="negative"><entity charOffset="130:139" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.40.e.0" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="therapy with verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="91:102" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.40.e.1" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="intolerant to propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.40.e.1" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.40.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.43" lineNumber="51" text="Concomitant administration of quinidine (See Drug Interactions ) preceded the severe hypotension in 3 of the 8 patients (2 of whom developed pulmonary edema). " type="irregular"><anaphoraRelation><anaphoraEntity charOffset="126:130" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.43.e.5" text="whom" type="Expression"/><antecedentEntity charOffset="109-119" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.43.e.6" text="8 patients" type="SPAN"/></anaphoraRelation><entity charOffset="85:96" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.43.e.1" text="hypotension" type="Specific_Interaction"/><entity charOffset="30:39" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.43.e.2" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="Concomitant administration of quinidine" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="100:119" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.43.e.3" text="3 of the 8 patients" type="SPAN"/><entity charOffset="109:119" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.43.e.6" text="8 patients" type="SPAN"/><entity charOffset="141:156" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.43.e.8" text="pulmonary edema" type="Specific_Interaction"><Normalization><mmtx cui="C0034063" phraseText="pulmonary edema" preferredWord="Pulmonary Edema" semType="dsyn"/></Normalization></entity><entity charOffset="121:130" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.43.e.9" text="2 of whom" type="SPAN"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.43.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.43.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.43.e.2"/></relation><relation type="hasEvidence"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.43.e.3"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.40" text="In 120 patients with hypertrophic cardiomyopathy (most of them refractory or intolerant to propranolol) who received therapy with verapamil at doses up to 720 mg/day, a variety of serious adverse effects were seen. "><entity charOffset="130:139" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.40.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="therapy with verapamil" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.41" text="Three patients died in pulmonary edema, all had severe left ventricular outflow obstruction and a past history of left ventricular dysfunction. "/><middleSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.42" text="Eight other patients had pulmonary edema and/or severe hypotension, abnormally high (over 20 mm Hg) capillary wedge pressure and a marked left ventricular outflow obstruction were present in most of these patients. "/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.43.ddi.2"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.43.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.43.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.40" text="In 120 patients with hypertrophic cardiomyopathy (most of them refractory or intolerant to propranolol) who received therapy with verapamil at doses up to 720 mg/day, a variety of serious adverse effects were seen. "><entity charOffset="130:139" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.40.e.0" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="therapy with verapamil" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.41" text="Three patients died in pulmonary edema, all had severe left ventricular outflow obstruction and a past history of left ventricular dysfunction. "/><middleSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.42" text="Eight other patients had pulmonary edema and/or severe hypotension, abnormally high (over 20 mm Hg) capillary wedge pressure and a marked left ventricular outflow obstruction were present in most of these patients. "/></relation><relation type="hasEvidence"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.43.e.9"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.43.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.56" lineNumber="61" text="It has been reported that verapamil decreases neuromuscular transmission in patients with Duchenne&quot;s muscular dystrophy, and that verapamil prolongs recovery from the neuromuscular blocking agent vecuronium and causes a worsening of myasthenia gravis. " type="regular"><entity charOffset="167:195" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.56.e.1" text="neuromuscular blocking agent" type="Drug_Class"><Normalization><mmtx cui="C0027866" phraseText="recovery from the neuromuscular blocking agent vecuronium" preferredWord="Neuromuscular Blocking Agents" semType="phsu"/><RxNorm RxCui="1036249"/></Normalization></entity><entity charOffset="196:206" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.56.e.2" text="vecuronium" type="Drug"><Normalization><mmtx cui="C0242531" phraseText="recovery from the neuromuscular blocking agent vecuronium" preferredWord="Vecuronium" semType="strd, phsu"/><RxNorm RxCui="71535"/></Normalization></entity><entity charOffset="140:157" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.56.e.4" text="prolongs recovery" type="Increase_Interaction"/><entity charOffset="130:139" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.56.e.5" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="that verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugClassMembership drug="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.56.e.2" drugClass="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.56.e.1"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.56.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.56.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.56.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.56.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.56.e.5" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.56.e.2" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.56.e.4" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="7" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69" lineNumber="73" text="Clinically significant interactions have been reported with inhibitors of CYP3A4 (eg, erythromycin, ritonavir) causing elevation of plasma levels of verapamil while inducers of CYP3A4 (eg, rifampin) have caused a lowering of plasma levels of verapamil. " type="regular"><entity charOffset="60:80" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.1" text="inhibitors of CYP3A4" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="86:98" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.2" text="erythromycin" type="Drug"><Normalization><mmtx cui="C0014806" phraseText="erythromycin," preferredWord="Erythromycin" semType="orch, antb"/><RxNorm RxCui="4053"/></Normalization></entity><entity charOffset="100:109" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.4" text="ritonavir" type="Drug"><Normalization><mmtx cui="C0292818" phraseText="ritonavir" preferredWord="Ritonavir" semType="phsu, orch"/><RxNorm RxCui="85762"/></Normalization></entity><entity charOffset="119:145" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.6" text="elevation of plasma levels" type="Increase_Interaction"/><entity charOffset="149:158" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.7" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="causing elevation of plasma levels of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><mmtx cui="C0042523" phraseText="causing elevation of plasma levels of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="165:183" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.9" text="inducers of CYP3A4" type="Drug_Class"><Normalization><RxNorm RxCui="993159"/></Normalization></entity><entity charOffset="189:197" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.10" text="rifampin" type="Drug"><Normalization><mmtx cui="C0035608" phraseText="rifampin" preferredWord="Rifampin" semType="orch, antb"/><RxNorm RxCui="9384"/></Normalization></entity><entity charOffset="213:238" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.12" text="lowering of plasma levels" type="Decrease_Interaction"/><entity charOffset="242:251" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.13" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="a lowering of plasma levels of verapamil." preferredWord="Verapamil" semType="phsu, orch"/><mmtx cui="C0042523" phraseText="a lowering of plasma levels of verapamil." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugClassMembership drug="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.2" drugClass="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.1"/><drugClassMembership drug="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.4" drugClass="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.1"/><drugClassMembership drug="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.10" drugClass="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.9"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.7"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.ddi.2"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.12"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.13"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.9"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.1" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.7" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.6" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.9" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.13" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.12" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.70" lineNumber="73" text="Hypotension, bradyarrhythmias, and lactic acidosis have been observed in patients receiving concurrent telithromycin, an antibiotic in the ketolide class of antibiotics." type="irregular"><entity charOffset="121:153" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.70.e.1" text="antibiotic in the ketolide class" type="Drug_Class"><Normalization><mmtx cui="C0003232" phraseText="an antibiotic in the ketolide class of antibiotics." preferredWord="Antibiotics" semType="antb"/><mmtx cui="C1449860" phraseText="an antibiotic in the ketolide class of antibiotics." preferredWord="Ketolides" semType="phsu, orch"/><RxNorm RxCui="901"/></Normalization></entity><entity charOffset="103:116" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.70.e.2" text="telithromycin" type="Drug"><Normalization><mmtx cui="C0907410" phraseText="concurrent telithromycin," preferredWord="telithromycin" semType="orch, antb"/><RxNorm RxCui="274786"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.70.e.4" text="Hypotension" type="Specific_Interaction"/><entity charOffset="13:29" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.70.e.6" text="bradyarrhythmias" type="Specific_Interaction"><Normalization><mmtx cui="C0079035" phraseText="bradyarrhythmias," preferredWord="Bradyarrhythmia (disorder)" semType="dsyn"/></Normalization></entity><entity charOffset="35:50" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.70.e.8" text="lactic acidosis" type="Specific_Interaction"><Normalization><mmtx cui="C0001125" phraseText="lactic acidosis" preferredWord="Acidosis, Lactic" semType="dsyn"/></Normalization></entity><drugClassMembership drug="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.70.e.2" drugClass="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.70.e.1"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.70.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.70.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.70.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69" text="Clinically significant interactions have been reported with inhibitors of CYP3A4 (eg, erythromycin, ritonavir) causing elevation of plasma levels of verapamil while inducers of CYP3A4 (eg, rifampin) have caused a lowering of plasma levels of verapamil. "><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.13"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.70.ddi.2"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.70.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.70.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69" text="Clinically significant interactions have been reported with inhibitors of CYP3A4 (eg, erythromycin, ritonavir) causing elevation of plasma levels of verapamil while inducers of CYP3A4 (eg, rifampin) have caused a lowering of plasma levels of verapamil. "><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.13"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.70.ddi.3"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.70.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.70.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69" text="Clinically significant interactions have been reported with inhibitors of CYP3A4 (eg, erythromycin, ritonavir) causing elevation of plasma levels of verapamil while inducers of CYP3A4 (eg, rifampin) have caused a lowering of plasma levels of verapamil. "><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.69.e.13"/></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.70.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.72" lineNumber="77" text="The use of HMG-CoA reductase inhibitors that are CYP3A4 substrates in combination with verapamil has been associated with reports of myopathy/rhabdomyolysis." type="regular"><entity charOffset="142:156" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.72.e.1" text="rhabdomyolysis" type="Specific_Interaction"/><entity charOffset="11:66" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.72.e.2" text="HMG-CoA reductase inhibitors that are CYP3A4 substrates" type="Drug_Class"><Normalization><mmtx cui="C0360714" phraseText="The use of HMG-CoA reductase inhibitors" preferredWord="Hydroxymethylglutaryl-CoA Reductase Inhibitors" semType="phsu, orch"/><RxNorm RxCui="27274"/></Normalization></entity><entity charOffset="87:96" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.72.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="with verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="133:141" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.72.e.5" text="myopathy" type="Specific_Interaction"><Normalization><mmtx cui="C0026848" phraseText="associated with reports of myopathy/rhabdomyolysis." preferredWord="Myopathy" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.72.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.72.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.72.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.72.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.72.ddi.2"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.72.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.72.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.72.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.72.e.2" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.72.e.3" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.72.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.73" lineNumber="78" text="Co-administration of multiple doses of 10 mg of verapamil with 80 mg simvastatin resulted in exposure to simvastatin 2.5-fold that following simvastatin alone. " type="regular"><entity charOffset="93:101|120:125" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.73.e.1" text="exposure -fold" type="Increase_Interaction"/><entity charOffset="105:116" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.73.e.2" text="simvastatin" type="Drug"><Normalization><mmtx cui="C0074554" phraseText="to simvastatin 2.5-fold" preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.73.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.73.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.73.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.74" lineNumber="78" text="Limit the dose of simvastatin in patients on verapamil to 10 mg daily. " type="regular"><entity charOffset="0:14" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.74.e.1" text="Limit the dose" type="Caution_Interaction"/><entity charOffset="45:54" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.74.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="on verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="18:29" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.74.e.3" text="simvastatin" type="Drug"><Normalization><mmtx cui="C0074554" phraseText="the dose of simvastatin" preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.74.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.74.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.74.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.74.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.74.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.74.e.2" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.74.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.75" lineNumber="78" text="Limit the daily dose of lovastatin to 40 mg. " type="irregular"><entity charOffset="0:20" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.75.e.1" text="Limit the daily dose" type="Caution_Interaction"/><entity charOffset="24:34" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.75.e.2" text="lovastatin" type="Drug"><Normalization><mmtx cui="C0024027" phraseText="the daily dose of lovastatin" preferredWord="Lovastatin" semType="phsu, orch"/><RxNorm RxCui="6472"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.75.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.75.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.75.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.74" text="Limit the dose of simvastatin in patients on verapamil to 10 mg daily. "><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.74.e.2"/></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.75.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76" lineNumber="78" text="Lower starting and maintenance doses of other CYP3A4 substrates (e.g., atorvastatin) may be required as verapamil may increase the plasma concentration of these drugs." type="regular"><anaphoraRelation><anaphoraEntity charOffset="155:166" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.6" text="these drugs" type="Expression"/><antecedentEntity charOffset="46-63" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.1" text="CYP3A4 substrates" type="Drug_Class"/></anaphoraRelation><entity charOffset="46:63" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.1" text="CYP3A4 substrates" type="Drug_Class"><Normalization><RxNorm RxCui="340933"/></Normalization></entity><entity charOffset="71:83" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.2" text="atorvastatin" type="Drug"><Normalization><mmtx cui="C0286651" phraseText="atorvastatin" preferredWord="atorvastatin" semType="phsu, orch"/><RxNorm RxCui="83367"/></Normalization></entity><entity charOffset="118:151" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.4" text="increase the plasma concentration" type="Increase_Interaction"/><entity charOffset="104:113" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.5" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="required as verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="0:36" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.9" text="Lower starting and maintenance doses" type="Caution_Interaction"/><drugClassMembership drug="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.2" drugClass="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.1"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.4"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.ddi.2"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.9"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.5" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.6" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.4" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.1" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.5" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.76.e.9" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78" lineNumber="82" text="Concomitant therapy with beta-adrenergic blockers and verapamil may result in additive negative effects on heart rate, atrioventricular conduction, and/or cardiac contractility. " type="regular"><entity charOffset="78:117" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.e.1" text="additive negative effects on heart rate" type="Specific_Interaction"/><entity charOffset="25:49" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.e.2" text="beta-adrenergic blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="Concomitant therapy with beta-adrenergic blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="54:63" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="78:106|119:146" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.e.5" text="additive negative effects on atrioventricular conduction" type="Specific_Interaction"/><entity charOffset="78:103|155:176" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.e.7" text="additive negative effects cardiac contractility" type="Specific_Interaction"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.ddi.2"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.ddi.3"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.e.2" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.e.3" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.78.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. " type="negative"><entity charOffset="37:46" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79.e.0" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="The combination of sustained-release verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="51:82" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79.e.1" text="beta-adrenergic blocking agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta-adrenergic blocking agents" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79.e.0" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79.e.1"/></sentence><sentence biomedicalEntities="0" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.80" lineNumber="82" text="However, there have been reports of excess bradycardia and AV block, including complete heart block, when the combination has been used for the treatment of hypertension." type="irregular"><entity charOffset="43:54" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.80.e.1" text="bradycardia" type="Specific_Interaction"/><entity charOffset="157:169" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.80.e.2" text="hypertension" type="SPAN"><Normalization><mmtx cui="C0020538" phraseText="used for the treatment of hypertension." preferredWord="Hypertensive disease" semType="dsyn"/></Normalization></entity><entity charOffset="59:67" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.80.e.4" text="AV block" type="Specific_Interaction"><Normalization><mmtx cui="C0004245" phraseText="AV block," preferredWord="Atrioventricular Block" semType="dsyn"/></Normalization></entity><entity charOffset="79:99" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.80.e.6" text="complete heart block" type="Specific_Interaction"><Normalization><mmtx cui="C0151517" phraseText="complete heart block," preferredWord="Complete atrioventricular block" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.80.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.80.e.1"><relations><relation type="hasContext"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.80.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. "><entity charOffset="51:82" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79.e.0" text="beta-adrenergic blocking agents" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-adrenergic blocking agents" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. "><entity charOffset="19:46" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79.e.1" text="sustained-release verapamil" type="Drug"><Normalization><mmtx cui="C2732140" phraseText="The combination of sustained-release verapamil" preferredWord="Sustain" semType="phsu, orch"/><mmtx cui="C0042523" phraseText="The combination of sustained-release verapamil" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.80.ddi.2"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.80.e.4"><relations><relation type="hasContext"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.80.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. "><entity charOffset="51:82" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79.e.0" text="beta-adrenergic blocking agents" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-adrenergic blocking agents" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. "><entity charOffset="19:46" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79.e.1" text="sustained-release verapamil" type="Drug"><Normalization><mmtx cui="C2732140" phraseText="The combination of sustained-release verapamil" preferredWord="Sustain" semType="phsu, orch"/><mmtx cui="C0042523" phraseText="The combination of sustained-release verapamil" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.80.ddi.3"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.80.e.6"><relations><relation type="hasContext"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.80.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. "><entity charOffset="51:82" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79.e.0" text="beta-adrenergic blocking agents" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-adrenergic blocking agents" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. "><entity charOffset="19:46" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79.e.1" text="sustained-release verapamil" type="Drug"><Normalization><mmtx cui="C2732140" phraseText="The combination of sustained-release verapamil" preferredWord="Sustain" semType="phsu, orch"/><mmtx cui="C0042523" phraseText="The combination of sustained-release verapamil" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="0" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.82" lineNumber="83" text="The combination should be used only with caution and close monitoring." type="irregular"><entity charOffset="41:48" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.82.e.1" text="caution" type="Caution_Interaction"/><entity charOffset="59:69" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.82.e.3" text="monitoring" type="Caution_Interaction"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.82.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.82.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. "><entity charOffset="51:82" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79.e.0" text="beta-adrenergic blocking agents" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-adrenergic blocking agents" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.80" text="However, there have been reports of excess bradycardia and AV block, including complete heart block, when the combination has been used for the treatment of hypertension."/><middleSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.81" text="For hypertensive patients, the risk of combined therapy may outweigh the potential benefits. "/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. "><entity charOffset="19:46" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79.e.1" text="sustained-release verapamil" type="Drug"><Normalization><mmtx cui="C2732140" phraseText="The combination of sustained-release verapamil" preferredWord="Sustain" semType="phsu, orch"/><mmtx cui="C0042523" phraseText="The combination of sustained-release verapamil" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.80" text="However, there have been reports of excess bradycardia and AV block, including complete heart block, when the combination has been used for the treatment of hypertension."/><middleSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.81" text="For hypertensive patients, the risk of combined therapy may outweigh the potential benefits. "/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.82.ddi.2"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.82.e.3"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. "><entity charOffset="51:82" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79.e.0" text="beta-adrenergic blocking agents" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-adrenergic blocking agents" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.80" text="However, there have been reports of excess bradycardia and AV block, including complete heart block, when the combination has been used for the treatment of hypertension."/><middleSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.81" text="For hypertensive patients, the risk of combined therapy may outweigh the potential benefits. "/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79" text="The combination of sustained-release verapamil and beta-adrenergic blocking agents has not been studied. "><entity charOffset="19:46" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.79.e.1" text="sustained-release verapamil" type="Drug"><Normalization><mmtx cui="C2732140" phraseText="The combination of sustained-release verapamil" preferredWord="Sustain" semType="phsu, orch"/><mmtx cui="C0042523" phraseText="The combination of sustained-release verapamil" preferredWord="Verapamil" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.80" text="However, there have been reports of excess bradycardia and AV block, including complete heart block, when the combination has been used for the treatment of hypertension."/><middleSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.81" text="For hypertensive patients, the risk of combined therapy may outweigh the potential benefits. "/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="3" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.83" lineNumber="84" text="Asymptomatic bradycardia (36 beats/min) with a wandering atrial pacemaker has been observed in a patient receiving concomitant timolol (a beta-adrenergic blocker) eyedrops and oral verapamil." type="regular"><entity charOffset="138:161" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.83.e.1" text="beta-adrenergic blocker" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="(a beta-adrenergic blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><mmtx cui="C3536830" phraseText="(a beta-adrenergic blocker" preferredWord="beta-Adrenergic Blocker [EPC]" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="127:134|163:171" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.83.e.2" text="timolol eyedrops" type="Drug"><Normalization><mmtx cui="C0040233" phraseText="concomitant timolol" preferredWord="Timolol" semType="phsu, orch"/><mmtx cui="C0001645" phraseText="(a beta-adrenergic blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><mmtx cui="C3536830" phraseText="(a beta-adrenergic blocker" preferredWord="beta-Adrenergic Blocker [EPC]" semType="phsu"/><RxNorm RxCui="42933"/></Normalization></entity><entity charOffset="0:73" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.83.e.4" text="Asymptomatic bradycardia (36 beats/min) with a wandering atrial pacemaker" type="Specific_Interaction"/><entity charOffset="176:190" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.83.e.5" text="oral verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="oral verapamil." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><drugClassMembership drug="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.83.e.2" drugClass="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.83.e.1"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.83.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.83.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.83.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.83.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.83.e.2" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.83.e.5" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.83.e.4" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.84" lineNumber="85" text="A decrease in metoprolol clearance has been reported when verapamil and metoprolol were administered together. " type="regular"><entity charOffset="2:13|25:34" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.84.e.1" text="decrease in clearance" type="Increase_Interaction"/><entity charOffset="58:67" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.84.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="14:24" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.84.e.3" text="metoprolol" type="Drug"><Normalization><mmtx cui="C0025859" phraseText="A decrease in metoprolol clearance" preferredWord="Metoprolol" semType="phsu, orch"/><RxNorm RxCui="6918"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.84.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.84.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.84.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.84.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.84.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.84.e.2" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.84.e.1" type="Increase_Interaction"/></sentence><sentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.85" text="A similar effect has not been observed when verapamil and atenolol are given together." type="negative"><entity charOffset="44:53" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.85.e.0" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="58:66" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.85.e.1" text="atenolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0004147" phraseText="atenolol" preferredWord="Atenolol" semType="phsu, orch"/><RxNorm RxCui="1202"/></Normalization></entity><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.85.e.0" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.85.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.87" lineNumber="89" text="Sinus bradycardia resulting in hospitalization and pacemaker insertion has been reported in association with the use of clonidine concurrently with verapamil. " type="regular"><entity charOffset="0:70" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.87.e.1" text="Sinus bradycardia resulting in hospitalization and pacemaker insertion" type="Specific_Interaction"/><entity charOffset="120:129" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.87.e.2" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="of clonidine concurrently" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="148:157" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.87.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="with verapamil." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.87.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.87.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.87.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.87.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.87.e.2" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.87.e.3" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.87.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.88" lineNumber="89" text="Monitor heart rate in patients receiving concomitant verapamil and clonidine." type="regular"><entity charOffset="0:7" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.88.e.1" text="Monitor" type="Caution_Interaction"/><entity charOffset="67:76" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.88.e.2" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="clonidine." preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="53:62" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.88.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="concomitant verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.88.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.88.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.88.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.88.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.88.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.88.e.2" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.88.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.90" lineNumber="93" text="Consider reducing digoxin dose when verapamil and digoxin are to be given together. " type="regular"><entity charOffset="9:17|26:30" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.90.e.1" text="reducing dose" type="Caution_Interaction"/><entity charOffset="36:45" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.90.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="18:25" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.90.e.3" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="reducing digoxin dose" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.90.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.90.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.90.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.90.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.90.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.90.e.2" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.90.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.91" lineNumber="93" text="Monitor digoxin level periodically during therapy. " type="irregular"><entity charOffset="0:7" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.91.e.1" text="Monitor" type="Caution_Interaction"/><entity charOffset="8:15" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.91.e.2" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="Monitor digoxin level periodically during therapy." preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.91.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.91.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.90" text="Consider reducing digoxin dose when verapamil and digoxin are to be given together. "><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.90.e.2"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.91.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.91.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92" lineNumber="93" text="Chronic verapamil treatment can increase serum digoxin levels by 50% to 75% during the first week of therapy, and this can result in digitalis toxicity. " type="regular"><entity charOffset="32:46|55:61" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.e.1" text="increase serum levels" type="Increase_Interaction"/><entity charOffset="47:54" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.e.2" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="serum digoxin levels by 50%" preferredWord="Digoxin" semType="strd, phsu, carb"/><mmtx cui="C0012265" phraseText="serum digoxin levels by 50%" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="8:17" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Chronic verapamil treatment" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="143:151" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.e.5" text="toxicity" type="Increase_Interaction"/><entity charOffset="133:142" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.e.6" text="digitalis" type="Drug"><Normalization><mmtx cui="C0304520" phraseText="result in digitalis toxicity." preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.ddi.2"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.e.5"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.e.2" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.e.6" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.92.e.5" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.93" lineNumber="93" text="In patients with hepatic cirrhosis the influence of verapamil on digoxin pharmacokinetics is magnified. " type="regular"><entity charOffset="73:102" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.93.e.1" text="pharmacokinetics is magnified" type="Increase_Interaction"/><entity charOffset="17:34" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.93.e.2" text="hepatic cirrhosis" type="SPAN"><Normalization><mmtx cui="C0023890" phraseText="with hepatic cirrhosis" preferredWord="Liver Cirrhosis" semType="dsyn"/></Normalization></entity><entity charOffset="52:61" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.93.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="the influence of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="65:72" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.93.e.4" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="on digoxin pharmacokinetics" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.93.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.93.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.93.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.93.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.93.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.93.e.2" ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.93.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.93.e.4" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.93.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.94" lineNumber="93" text="Verapamil may reduce total body clearance and extrarenal clearance of digoxin by 27% and 29%, respectively. " type="regular"><entity charOffset="14:41" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.94.e.1" text="reduce total body clearance" type="Increase_Interaction"/><entity charOffset="0:9" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.94.e.2" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="70:77" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.94.e.3" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="extrarenal clearance of digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="14:20|46:66" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.94.e.5" text="reduce extrarenal clearance" type="Increase_Interaction"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.94.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.94.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.94.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.94.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.94.ddi.2"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.94.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.94.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.94.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.94.e.2" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.94.e.3" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.94.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96" lineNumber="94" text="In previous clinical trials with other verapamil formulations related to the control of ventricular response in patients taking digoxin who had atrial fibrillation or atrial flutter, ventricular rates below 50/min at rest occurred in 15% of patients, and asymptomatic hypotension occurred in 5% of patients." type="regular"><entity charOffset="183:221" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.1" text="ventricular rates below 50/min at rest" type="Specific_Interaction"/><entity charOffset="39:48" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="with other verapamil formulations" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="167:181" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.3" text="atrial flutter" type="SPAN"/><entity charOffset="144:163" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.4" text="atrial fibrillation" type="SPAN"><Normalization><mmtx cui="C0232197" phraseText="atrial fibrillation" preferredWord="Fibrillation" semType="dsyn"/></Normalization></entity><entity charOffset="128:135" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.5" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="234:249" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.6" text="15% of patients" type="SPAN"/><entity charOffset="255:279" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.8" text="asymptomatic hypotension" type="Specific_Interaction"/><entity charOffset="292:306" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.9" text="5% of patients" type="SPAN"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.5"/></relation><relation type="hasEvidence"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.6"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.ddi.2"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.8"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.4"/></relation><relation type="hasEvidence"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.9"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.5"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.3, Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.4" ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.2" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.5" evidence="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.6" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.96.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="6" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98" lineNumber="98" text="Verapamil administered concomitantly with oral antihypertensive agents (e.g., vasodilators, angiotensin-converting enzyme inhibitors, diuretics, beta blockers) will usually have an additive effect on lowering blood pressure. " type="regular"><entity charOffset="42:70" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.1" text="oral antihypertensive agents" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="concomitantly with oral antihypertensive agents" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="78:90" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.2" text="vasodilators" type="Drug_Class"><Normalization><mmtx cui="C0042402" phraseText="vasodilators," preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="92:132" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.4" text="angiotensin-converting enzyme inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="angiotensin-converting enzyme inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="6162"/></Normalization></entity><entity charOffset="134:143" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.6" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="145:158" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.8" text="beta blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="181:223" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.10" text="additive effect on lowering blood pressure" type="Specific_Interaction"/><entity charOffset="0:9" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.11" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><classClassMembership drugClass="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.2"/><classClassMembership drugClass="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.4"/><classClassMembership drugClass="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.6"/><classClassMembership drugClass="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.8"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.10"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.11"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.11" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.1" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.10" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.99" lineNumber="98" text="Patients receiving these combinations should be appropriately monitored. " type="irregular"><entity charOffset="62:71" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.99.e.1" text="monitored" type="Caution_Interaction"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.99.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.99.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98" text="Verapamil administered concomitantly with oral antihypertensive agents (e.g., vasodilators, angiotensin-converting enzyme inhibitors, diuretics, beta blockers) will usually have an additive effect on lowering blood pressure. "><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.11"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98" text="Verapamil administered concomitantly with oral antihypertensive agents (e.g., vasodilators, angiotensin-converting enzyme inhibitors, diuretics, beta blockers) will usually have an additive effect on lowering blood pressure. "><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.98.e.1"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.100" lineNumber="98" text="Concomitant use of agents that attenuate alpha-adrenergic function with verapamil may result in reduction in blood pressure that is excessive in some patients. " type="regular"><entity charOffset="96:141" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.100.e.1" text="reduction in blood pressure that is excessive" type="Specific_Interaction"/><entity charOffset="19:66" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.100.e.2" text="agents that attenuate alpha-adrenergic function" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="Concomitant use of agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><entity charOffset="72:81" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.100.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="alpha-adrenergic function with verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="96:141" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.100.e.4" text="reduction in blood pressure that is excessive" type="SPAN"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.100.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.100.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.100.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.100.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.100.e.2" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.100.e.3" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.100.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.101" lineNumber="98" text="Such an effect was observed in one study following the concomitant administration of verapamil and prazosin." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.100" Text="Concomitant use of agents that attenuate alpha-adrenergic function with verapamil may result in reduction in blood pressure that is excessive in some patients. "/><anaphoraEntity charOffset="0:14" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.101.e.1" text="Such an effect" type="Expression"/><antecedentEntity charOffset="96:141" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.100.e.1" text="reduction in blood pressure that is excessive" type="Specific_Interaction"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.100" Text="Concomitant use of agents that attenuate alpha-adrenergic function with verapamil may result in reduction in blood pressure that is excessive in some patients. "/><anaphoraEntity charOffset="0:14" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.101.e.1" text="Such an effect" type="Expression"/><antecedentEntity charOffset="96:141" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.100.e.4" text="reduction in blood pressure that is excessive" type="SPAN"/></anaphoraRelation><entity charOffset="0:14" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.101.e.3" text="Such an effect" type="Specific_Interaction"/><entity charOffset="85:94" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.101.e.4" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="the concomitant administration of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="99:107" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.101.e.5" text="prazosin" type="Drug"><Normalization><mmtx cui="C0032912" phraseText="prazosin." preferredWord="Prazosin" semType="phsu, orch"/><RxNorm RxCui="8629"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.101.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.101.e.3"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.101.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.101.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.101.e.4" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.101.e.5" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.101.e.3" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.103" lineNumber="102" text="Disopyramide: Until data on possible interactions between verapamil and disopyramide phosphate are obtained, disopyramide should not be administered within 48 hours before or 24 hours after verapamil administration." type="regular"><anaphoraRelation><anaphoraEntity charOffset="109:121" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.103.e.2" text="disopyramide" type="Drug"/><antecedentEntity charOffset="72-94" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.103.e.5" text="disopyramide phosphate" type="Drug"/></anaphoraRelation><entity charOffset="129:155|159:174|178:189" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.103.e.1" text="not be administered within hours before or hours after" type="Caution_Interaction"/><entity charOffset="109:121" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.103.e.2" text="disopyramide" type="Drug"><Normalization><mmtx cui="C0012702" phraseText="disopyramide" preferredWord="Disopyramide" semType="phsu, orch"/><RxNorm RxCui="3541"/></Normalization></entity><entity charOffset="190:199" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.103.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="24 hours after verapamil administration." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="72:94" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.103.e.5" text="disopyramide phosphate" type="Drug"><Normalization><mmtx cui="C0700534" phraseText="disopyramide phosphate" preferredWord="Disopyramide Phosphate" semType="phsu, orch"/><RxNorm RxCui="3541"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.103.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.103.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.103.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.103.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.103.e.2" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.103.e.3" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.103.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104" lineNumber="103" text="Flecainide: A study in healthy volunteers showed that the concomitant administration of flecainide and verapamil may have additive effects on myocardial contractility, AV conduction, and repolarization. " type="regular"><entity charOffset="122:166" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.e.1" text="additive effects on myocardial contractility" type="Specific_Interaction"/><entity charOffset="88:98" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.e.2" text="flecainide" type="Drug"><Normalization><mmtx cui="C0016229" phraseText="the concomitant administration of flecainide" preferredWord="Flecainide" semType="phsu, orch"/><RxNorm RxCui="4441"/></Normalization></entity><entity charOffset="103:112" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="122:141|168:181" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.e.5" text="additive effects on AV conduction" type="Specific_Interaction"/><entity charOffset="122:141|187:201" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.e.7" text="additive effects on repolarization" type="Specific_Interaction"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.ddi.2"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.ddi.3"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.e.2" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.e.3" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.104.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.105" lineNumber="103" text="Concomitant therapy with flecainide and verapamil may result in additive negative inotropic effect and prolongation of atrioventricular conduction." type="regular"><entity charOffset="64:98" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.105.e.1" text="additive negative inotropic effect" type="Specific_Interaction"/><entity charOffset="40:49" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.105.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="25:35" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.105.e.3" text="flecainide" type="Drug"><Normalization><mmtx cui="C0016229" phraseText="Concomitant therapy with flecainide" preferredWord="Flecainide" semType="phsu, orch"/><RxNorm RxCui="4441"/></Normalization></entity><entity charOffset="103:146" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.105.e.5" text="prolongation of atrioventricular conduction" type="Specific_Interaction"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.105.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.105.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.105.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.105.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.105.ddi.2"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.105.e.5"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.105.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.105.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.105.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.105.e.2" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.105.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.106" lineNumber="104" text="Quinidine: In a small number of patients with hypertrophic cardiomyopathy (IHSS), concomitant use of verapamil and quinidine resulted in significant hypotension. " type="regular"><entity charOffset="149:160" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.106.e.1" text="hypotension" type="Specific_Interaction"/><entity charOffset="16:40" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.106.e.2" text="small number of patients" type="SPAN"/><entity charOffset="46:73" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.106.e.3" text="hypertrophic cardiomyopathy" type="SPAN"><Normalization><mmtx cui="C0007194" phraseText="with hypertrophic cardiomyopathy" preferredWord="Hypertrophic Cardiomyopathy" semType="dsyn"/></Normalization></entity><entity charOffset="115:124" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.106.e.4" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="quinidine" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="101:110" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.106.e.5" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="concomitant use of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.106.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.106.e.1"><relations><relation type="hasContext"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.106.e.3"/></relation><relation type="hasEvidence"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.106.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.106.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.106.e.5"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.106.e.3" ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.106.e.5" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.106.e.4" evidence="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.106.e.2" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.106.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.107" lineNumber="104" text="Until further data are obtained, combined therapy of verapamil and quinidine in patients with hypertrophic cardiomyopathy should probably be avoided.. " type="regular"><entity charOffset="141:148" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.107.e.1" text="avoided" type="Caution_Interaction"/><entity charOffset="67:76" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.107.e.2" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="quinidine in patients" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="53:62" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.107.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="combined therapy of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="94:121" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.107.e.4" text="hypertrophic cardiomyopathy" type="SPAN"><Normalization><mmtx cui="C0007194" phraseText="with hypertrophic cardiomyopathy" preferredWord="Hypertrophic Cardiomyopathy" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.107.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.107.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.107.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.107.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.107.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.107.e.4" ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.107.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.107.e.2" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.107.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.108" text="The electrophysiological effects of quinidine and verapamil on AV conduction were studied in 8 patients. " type="negative"><entity charOffset="36:45" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.108.e.0" text="quinidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0034414" phraseText="The electrophysiological effects of quinidine" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="50:59" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.108.e.1" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="verapamil on AV conduction" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.108.e.0" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.108.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.109" lineNumber="104" text="Verapamil significantly counteracted the effects of quinidine on AV conduction. " type="regular"><entity charOffset="24:48|62:78" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.109.e.1" text="counteracted the effects on AV conduction" type="Specific_Interaction"/><entity charOffset="0:9" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.109.e.2" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil significantly" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="52:61" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.109.e.3" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="the effects of quinidine" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.109.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.109.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.109.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.109.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.109.e.2" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.109.e.3" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.109.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.110" lineNumber="104" text="There has been a report of increased quinidine levels during verapamil therapy." type="regular"><entity charOffset="27:36|47:53" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.110.e.1" text="increased levels" type="Increase_Interaction"/><entity charOffset="15:23" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.110.e.2" text="a report" type="SPAN"/><entity charOffset="61:70" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.110.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="during verapamil therapy." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="37:46" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.110.e.4" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="a report of increased quinidine levels" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.110.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.110.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.110.e.3"/></relation><relation type="hasEvidence"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.110.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.110.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.110.e.4" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.110.e.3" evidence="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.110.e.2" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.110.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113" lineNumber="106" text="Alcohol: Verapamil has been found to significantly inhibit ethanol elimination resulting in elevated blood ethanol concentrations that may prolong the intoxicating effects of alcohol. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="175:182" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.8" text="alcohol" type="Expression"/><antecedentEntity charOffset="107-114" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.2" text="ethanol" type="Substance"/></anaphoraRelation><entity charOffset="92:106|115:129" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.1" text="elevated blood concentrations" type="Increase_Interaction"/><entity charOffset="107:114" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.2" text="ethanol" type="Substance"><Normalization><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="9:18" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.3" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="51:58|67:78" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.5" text="inhibit elimination" type="Increase_Interaction"><Normalization><mmtx cui="C0018790" phraseText="inhibit" preferredWord="Cardiac Arrest" semType="dsyn"/></Normalization></entity><entity charOffset="59:66" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.6" text="ethanol" type="Substance"><Normalization><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="139:171" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.10" text="prolong the intoxicating effects" type="Specific_Interaction"/><entity charOffset="175:182" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.11" text="alcohol" type="Substance"><Normalization><RxNorm RxCui="448"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.ddi.2"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.6"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.ddi.3"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.10"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.11"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.2" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.6" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.5" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.11" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.113.e.10" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.116" lineNumber="110" text="Aspirin: In a few reported cases, coadministration of verapamil with aspirin has led to increased bleeding times greater than observed with aspirin alone." type="regular"><entity charOffset="88:112" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.116.e.1" text="increased bleeding times" type="Specific_Interaction"/><entity charOffset="14:32" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.116.e.2" text="few reported cases" type="SPAN"/><entity charOffset="69:76" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.116.e.3" text="aspirin" type="Drug"><Normalization><mmtx cui="C0004057" phraseText="with aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="54:63" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.116.e.4" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="coadministration of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.116.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.116.e.1"><relations><relation type="hasEvidence"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.116.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.116.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.116.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.116.e.4" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.116.e.3" evidence="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.116.e.2" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.116.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.117" text="Cimetidine: The interaction between cimetidine and chronically administered verapamil has not been studied. " type="negative"><entity charOffset="0:10" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.117.e.0" text="cimetidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0008783" phraseText="Cimetidine" preferredWord="Cimetidine" semType="phsu, orch"/><RxNorm RxCui="2541"/></Normalization></entity><entity charOffset="36:46" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.117.e.1" text="cimetidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0008783" phraseText="The interaction between cimetidine" preferredWord="Cimetidine" semType="phsu, orch"/><RxNorm RxCui="2541"/></Normalization></entity><entity charOffset="76:85" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.117.e.2" text="verapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0042523" phraseText="chronically administered verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.117.e.0" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.117.e.2"/><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.117.e.1" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.117.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.119" lineNumber="112" text="Grapefruit Juice: Grapefruit juice may significantly increase concentrations of verapamil. " type="regular"><entity charOffset="53:76" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.119.e.1" text="increase concentrations" type="Increase_Interaction"/><entity charOffset="18:34" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.119.e.2" text="Grapefruit juice" type="Substance"><Normalization><mmtx cui="C0440280" phraseText="Grapefruit juice" preferredWord="GRAPEFRUIT EXTRACT" semType="phsu, orch"/><RxNorm RxCui="124323"/></Normalization></entity><entity charOffset="80:89" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.119.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="concentrations of verapamil." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.119.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.119.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.119.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.119.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.119.e.2" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.119.e.3" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.119.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.120" lineNumber="112" text="Grapefruit juice given to nine healthy volunteers increased S- and R- verapamil AUC0-12 by 36% and 28%, respectively. " type="regular"><entity charOffset="50:59|80:87" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.120.e.1" text="increased AUC0-12" type="Increase_Interaction"/><entity charOffset="70:79" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.120.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0280858" phraseText="R- verapamil AUC0-12 by 36%" preferredWord="Dexverapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="0:16" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.120.e.3" text="Grapefruit juice" type="Substance"><Normalization><mmtx cui="C0440280" phraseText="Grapefruit juice" preferredWord="GRAPEFRUIT EXTRACT" semType="phsu, orch"/><RxNorm RxCui="124323"/></Normalization></entity><entity charOffset="26:49" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.120.e.4" text="nine healthy volunteers" type="SPAN"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.120.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.120.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.120.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.120.e.3"/></relation><relation type="hasEvidence"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.120.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.120.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.120.e.2" evidence="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.120.e.4" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.120.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121" lineNumber="112" text="Steady state Cmax and Cmin of S-verapamil increased by 57% and 16.7%, respectively with grapefruit juice compared to control. " type="regular"><entity charOffset="0:17|42:51" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121.e.1" text="Steady state Cmax increased" type="Increase_Interaction"/><entity charOffset="88:104" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121.e.2" text="grapefruit juice" type="Substance"><Normalization><mmtx cui="C0440280" phraseText="respectively with grapefruit juice" preferredWord="GRAPEFRUIT EXTRACT" semType="phsu, orch"/><RxNorm RxCui="124323"/></Normalization></entity><entity charOffset="32:41" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Cmin of S-verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="0:12|22:26|42:51" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121.e.5" text="Steady state Cmin increased" type="Increase_Interaction"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121.ddi.2"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121.e.2" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.122" lineNumber="112" text="Similarly, Cmax and Cmin of R-verapamil increased by 40% and 13%, respectively. " type="irregular"><entity charOffset="11:15|40:49" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.122.e.1" text="Cmax increased" type="Increase_Interaction"/><entity charOffset="30:39" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.122.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0280858" phraseText="Cmin of R-verapamil" preferredWord="Dexverapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="20:24|40:49" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.122.e.4" text="Cmin increased" type="Increase_Interaction"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.122.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.122.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.122.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121" text="Steady state Cmax and Cmin of S-verapamil increased by 57% and 16.7%, respectively with grapefruit juice compared to control. "><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121.e.2"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.122.ddi.2"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.122.e.4"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.122.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121" text="Steady state Cmax and Cmin of S-verapamil increased by 57% and 16.7%, respectively with grapefruit juice compared to control. "><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.121.e.2"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.123" text="Grapefruit juice did not affect half-life, nor was there a significant change in AUC0-12 ratio R/S compared to control. " type="negative"><entity charOffset="57:88" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.123.e.0" text="a 12" type="Biomedical_Entity"><Normalization><mmtx cui="C0620347" phraseText="a significant change in AUC0-12 ratio" preferredWord="compound A 12" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="0:10" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.123.e.1" text="grapefruit" type="Biomedical_Entity"><Normalization><mmtx cui="C0440280" phraseText="Grapefruit juice" preferredWord="GRAPEFRUIT EXTRACT" semType="phsu, orch"/><RxNorm RxCui="124323"/></Normalization></entity><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.123.e.1" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.123.e.0"/></sentence><sentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.124" text="Grapefruit juice did not cause a significant difference in the PK of norverapamil. " type="negative"><entity charOffset="69:81" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.124.e.0" text="norverapamil" type="Biomedical_Entity"><Normalization><mmtx cui="C0069036" phraseText="a significant difference in the PK of norverapamil." preferredWord="norverapamil" semType="phsu, orch"/><RxNorm RxCui="32033"/></Normalization></entity><entity charOffset="0:10" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.124.e.1" text="grapefruit" type="Biomedical_Entity"><Normalization><mmtx cui="C0440280" phraseText="Grapefruit juice" preferredWord="GRAPEFRUIT EXTRACT" semType="phsu, orch"/><RxNorm RxCui="124323"/></Normalization></entity><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.124.e.1" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.124.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126" lineNumber="113" text="Lithium: Pharmacokinetic and pharmacodynamic interactions between oral verapamil and lithium have been reported. " type="regular"><entity charOffset="9:24|45:57" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126.e.1" text="Pharmacokinetic interactions" type="Specific_Interaction"/><entity charOffset="85:92" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="66:80" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126.e.3" text="oral verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="pharmacodynamic interactions between oral verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="29:57" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126.e.5" text="pharmacodynamic interactions" type="Specific_Interaction"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126.ddi.2"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126.e.2" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.127" lineNumber="113" text="The former may result in a lowering of serum lithium levels in patients receiving chronic stable oral lithium therapy. " type="irregular"><entity charOffset="27:44|53:59" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.127.e.1" text="lowering of serum levels" type="Decrease_Interaction"/><entity charOffset="45:52" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.127.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C1441405" phraseText="result in a lowering of serum lithium levels" preferredWord="Lithium.serum" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.127.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.127.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126" text="Lithium: Pharmacokinetic and pharmacodynamic interactions between oral verapamil and lithium have been reported. "><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126.e.3"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.127.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="1" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.128" lineNumber="113" text="The latter may result in an increased sensitivity to the effects of lithium. " type="irregular"><entity charOffset="28:64" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.128.e.1" text="increased sensitivity to the effects" type="Specific_Interaction"/><entity charOffset="68:75" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.128.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="of lithium." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.128.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.128.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126" text="Lithium: Pharmacokinetic and pharmacodynamic interactions between oral verapamil and lithium have been reported. "><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126.e.3"/></ellipsisSentence><middleSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.127" text="The former may result in a lowering of serum lithium levels in patients receiving chronic stable oral lithium therapy. "/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.128.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="0" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.129" lineNumber="113" text="Patients receiving both drugs must be monitored carefully." type="irregular"><entity charOffset="38:47" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.129.e.1" text="monitored" type="Caution_Interaction"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.129.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.129.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.128" text="The latter may result in an increased sensitivity to the effects of lithium. "><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.128.e.2"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126" text="Lithium: Pharmacokinetic and pharmacodynamic interactions between oral verapamil and lithium have been reported. "><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.126.e.3"/></ellipsisSentence><middleSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.127" text="The former may result in a lowering of serum lithium levels in patients receiving chronic stable oral lithium therapy. "/><middleSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.128" text="The latter may result in an increased sensitivity to the effects of lithium. "/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130" lineNumber="114" text="Carbamazepine: Verapamil therapy may increase carbamazepine concentrations during combined therapy. " type="regular"><entity charOffset="37:45|60:74" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130.e.1" text="increase concentrations" type="Increase_Interaction"/><entity charOffset="15:24" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130.e.2" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil therapy" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="46:59" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130.e.3" text="carbamazepine" type="Drug"><Normalization><mmtx cui="C0006949" phraseText="carbamazepine concentrations during combined therapy." preferredWord="Carbamazepine" semType="phsu, orch"/><RxNorm RxCui="2002"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130.e.2" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130.e.3" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131" lineNumber="114" text="This may produce carbamazepine side effects such as diplopia, headache, ataxia, or dizziness." type="irregular"><entity charOffset="52:60" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131.e.1" text="diplopia" type="Specific_Interaction"><Normalization><mmtx cui="C0012569" phraseText="carbamazepine side effects such as diplopia," preferredWord="Diplopia" semType="dsyn"/></Normalization></entity><entity charOffset="17:30" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131.e.2" text="carbamazepine" type="Drug"><Normalization><mmtx cui="C0006949" phraseText="carbamazepine side effects such as diplopia," preferredWord="Carbamazepine" semType="phsu, orch"/><RxNorm RxCui="2002"/></Normalization></entity><entity charOffset="62:70" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131.e.4" text="headache" type="Specific_Interaction"><Normalization><mmtx cui="C0018681" phraseText="headache," preferredWord="Headache" semType="sosy"/></Normalization></entity><entity charOffset="72:78" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131.e.6" text="ataxia" type="Specific_Interaction"><Normalization><mmtx cui="C0004134" phraseText="ataxia," preferredWord="Ataxia" semType="sosy"/></Normalization></entity><entity charOffset="83:92" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131.e.8" text="dizziness" type="Specific_Interaction"><Normalization><mmtx cui="C0012833" phraseText="dizziness." preferredWord="Dizziness" semType="sosy"/><mmtx cui="C0042571" phraseText="dizziness." preferredWord="Vertigo" semType="sosy"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130" text="Carbamazepine: Verapamil therapy may increase carbamazepine concentrations during combined therapy. "><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130.e.2"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131.ddi.2"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130" text="Carbamazepine: Verapamil therapy may increase carbamazepine concentrations during combined therapy. "><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130.e.2"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131.ddi.3"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130" text="Carbamazepine: Verapamil therapy may increase carbamazepine concentrations during combined therapy. "><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130.e.2"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131.ddi.4"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130" text="Carbamazepine: Verapamil therapy may increase carbamazepine concentrations during combined therapy. "><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.130.e.2"/></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.131.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.132" lineNumber="115" text="Rifampin: Therapy with rifampin may markedly reduce oral verapamil bioavailability." type="regular"><entity charOffset="45:51|67:82" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.132.e.1" text="reduce bioavailability" type="Decrease_Interaction"/><entity charOffset="52:66" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.132.e.2" text="oral verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="oral verapamil bioavailability." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="23:31" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.132.e.3" text="rifampin" type="Drug"><Normalization><mmtx cui="C0035608" phraseText="Therapy with rifampin" preferredWord="Rifampin" semType="orch, antb"/><RxNorm RxCui="9384"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.132.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.132.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.132.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.132.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.132.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.132.e.2" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.132.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.133" lineNumber="116" text="Phenobarbital: Phenobarbital therapy may increase verapamil clearance." type="regular"><entity charOffset="41:49|60:69" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.133.e.1" text="increase clearance" type="Decrease_Interaction"/><entity charOffset="50:59" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.133.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil clearance." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="15:28" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.133.e.3" text="Phenobarbital" type="Drug"><Normalization><mmtx cui="C0031412" phraseText="Phenobarbital therapy" preferredWord="Phenobarbital" semType="phsu, orch"/><RxNorm RxCui="8134"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.133.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.133.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.133.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.133.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.133.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.133.e.2" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.133.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.134" lineNumber="117" text="Cyclosporine: Verapamil therapy may increase serum levels of cyclosporine." type="regular"><entity charOffset="36:57" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.134.e.1" text="increase serum levels" type="Increase_Interaction"/><entity charOffset="61:73" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.134.e.2" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="serum levels of cyclosporine." preferredWord="Cyclosporine" semType="phsu, aapp"/><mmtx cui="C0010592" phraseText="serum levels of cyclosporine." preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="14:23" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.134.e.3" text="Verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="Verapamil therapy" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.134.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.134.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.134.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.134.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.134.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.134.e.2" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.134.e.1" type="Increase_Interaction"/></sentence><sentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.135" text="Inhalation Anesthetics: Animal experiments have shown that inhalation anesthetics depress cardiovascular activity by decreasing the inward movement of calcium ions. " type="negative"><entity charOffset="0:22" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.135.e.0" text="inhalation anesthetics" type="Biomedical_Entity"><Normalization><mmtx cui="C0242903" phraseText="Inhalation Anesthetics" preferredWord="Anesthetics, Inhalation" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="59:81" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.135.e.1" text="inhalation anesthetics" type="Biomedical_Entity"><Normalization><mmtx cui="C0242903" phraseText="that inhalation anesthetics" preferredWord="Anesthetics, Inhalation" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="151:163" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.135.e.2" text="calcium ions" type="Biomedical_Entity"><Normalization><mmtx cui="C0596235" phraseText="the inward movement of calcium ions." preferredWord="Calcium ion" semType="phsu, elii"/><RxNorm RxCui="1895"/></Normalization></entity><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.135.e.0" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.135.e.2"/><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.135.e.1" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.135.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.136" lineNumber="118" text="When used concomitantly, inhalation anesthetics and calcium antagonists, such as verapamil, should be titrated carefully to avoid excessive cardiovascular depression." type="regular"><entity charOffset="52:71" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.136.e.1" text="calcium antagonists" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="calcium antagonists," preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="81:90" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.136.e.2" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="such as verapamil," preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="130:165" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.136.e.4" text="excessive cardiovascular depression" type="Specific_Interaction"/><entity charOffset="25:47" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.136.e.5" text="inhalation anesthetics" type="Drug_Class"><Normalization><mmtx cui="C0242903" phraseText="inhalation anesthetics" preferredWord="Anesthetics, Inhalation" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugClassMembership drug="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.136.e.2" drugClass="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.136.e.1"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.136.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.136.e.4"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.136.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.136.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.136.e.5" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.136.e.1" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.136.e.4" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137" lineNumber="119" text="Neuromuscular Blocking Agents: Clinical data and animal studies suggest that verapamil may potentiate the activity of neuromuscular blocking agents (curare-like and depolarizing). " type="regular"><entity charOffset="91:114" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.1" text="potentiate the activity" type="Increase_Interaction"/><entity charOffset="118:147|165:177" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.2" text="neuromuscular blocking agents depolarizing" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="the activity of neuromuscular blocking agents" preferredWord="Pharmacologic Substance" semType="phsu"/><mmtx cui="C0010463" phraseText="(curare-" preferredWord="Curare" semType="phsu, orch, hops"/><RxNorm RxCui="1036249"/></Normalization></entity><entity charOffset="118:147|149:160" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.3" text="neuromuscular blocking agents curare-like" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="the activity of neuromuscular blocking agents" preferredWord="Pharmacologic Substance" semType="phsu"/><mmtx cui="C0010463" phraseText="(curare-" preferredWord="Curare" semType="phsu, orch, hops"/><RxNorm RxCui="1036249"/></Normalization></entity><entity charOffset="77:86" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.4" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="that verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="49:63" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.5" text="animal studies" type="SPAN"/><entity charOffset="118:147|149:160" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.6" text="neuromuscular blocking agents curare-like" type="SPAN"/><entity charOffset="118:147|165:177" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.7" text="neuromuscular blocking agents depolarizing" type="SPAN"/><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.1"><relations><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.4"/></relation><relation type="hasEvidence"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.4" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.2" evidence="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.5" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.4" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.3" evidence="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.5" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.138" lineNumber="119" text="It may be necessary to decrease the dose of verapamil and/or the dose of the neuromuscular blocking agent when the drugs are used concomitantly." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137" Text="Neuromuscular Blocking Agents: Clinical data and animal studies suggest that verapamil may potentiate the activity of neuromuscular blocking agents (curare-like and depolarizing). "/><anaphoraEntity charOffset="77:105" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.138.e.2" text="neuromuscular blocking agent" type="Expression"/><antecedentEntity charOffset="118:160" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.3" text="neuromuscular blocking agents curare-like" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137" Text="Neuromuscular Blocking Agents: Clinical data and animal studies suggest that verapamil may potentiate the activity of neuromuscular blocking agents (curare-like and depolarizing). "/><anaphoraEntity charOffset="77:105" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.138.e.2" text="neuromuscular blocking agent" type="Expression"/><antecedentEntity charOffset="118:160" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.6" text="neuromuscular blocking agents curare-like" type="SPAN"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137" Text="Neuromuscular Blocking Agents: Clinical data and animal studies suggest that verapamil may potentiate the activity of neuromuscular blocking agents (curare-like and depolarizing). "/><anaphoraEntity charOffset="77:105" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.138.e.2" text="neuromuscular blocking agent" type="Expression"/><antecedentEntity charOffset="118:177" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.2" text="neuromuscular blocking agents depolarizing" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137" Text="Neuromuscular Blocking Agents: Clinical data and animal studies suggest that verapamil may potentiate the activity of neuromuscular blocking agents (curare-like and depolarizing). "/><anaphoraEntity charOffset="77:105" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.138.e.2" text="neuromuscular blocking agent" type="Expression"/><antecedentEntity charOffset="118:177" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.137.e.7" text="neuromuscular blocking agents depolarizing" type="SPAN"/></anaphoraRelation><entity charOffset="23:40" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.138.e.1" text="decrease the dose" type="Caution_Interaction"/><entity charOffset="44:53" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.138.e.3" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="the dose of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.138.ddi.1"><interaction trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.138.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.138.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.138.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.138.e.3" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.138.e.2" trigger="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.138.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.155" text="Such adverse experiences have not been reported in the literature, despite a long history of use of verapamil HCl in Europe in the treatment of cardiac side effects of beta-adrenergic agonist agents used to treat premature labor." type="negative"><entity charOffset="168:191" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.155.e.0" text="beta-adrenergic agonist" type="Biomedical_Entity"><Normalization><mmtx cui="C0001644" phraseText="of beta-adrenergic agonist agents" preferredWord="Adrenergic beta-Agonists" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="100:113" id="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.155.e.1" text="verapamil hcl" type="Biomedical_Entity"><Normalization><mmtx cui="C0700468" phraseText="of verapamil HCl" preferredWord="Verapamil hydrochloride" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><pair ddi="false" e1="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.155.e.1" e2="Dailymed.0742cf97-601b-4c13-a6c3-1a6a616ed292.s.155.e.0"/></sentence><positiveExamples number="50"/><negativeExamples number="20"/></document>